UK's MHRA:

  • UK'S MHRA: SEMAGLUTIDE INJECTION APPROVED TO TREAT METABOLIC-ASSOCIATED STEATOHEPATITIS IN ADULTS WITH MODERATE-TO-ADVANCED LIVER FIBROSIS